Lang, Katharina M. https://orcid.org/0000-0001-8855-884X
Harrison, Kathryn L.
Williamson, Paula R.
Huntly, Brian J. P.
Ossenkoppele, Gert
Geissler, Jan
Bereczky, Tamàs
Hernández-Rivas, Jesús M.
Chevrou-Séverac, Hélène
Goodbody, Rory
Schulze-Rath, Renate
Bullinger, Lars
Funding for this research was provided by:
Innovative Medicine Initiative (IMI) 2 (116026)
Bayer AG (Cash Grant - HARMONY project)
Article History
Received: 24 July 2019
Accepted: 6 May 2020
First Online: 27 May 2020
Ethics approval and consent to participate
: The HARMONY Alliance is structured into eight WPs, of which WP 8 is responsible for ethical aspects of the project. Further information can be found at . In consultation with the WP 8, the development and conducting of the Delphi survey were performed, and ethics approval is not required. Recruitment of participants is carried out within the HARMONY Alliance. Patient recruitment is carried out by patient umbrella organizations, partners in HARMONY. Before registration, all study participants receive information about the study, and informed consent is obtained from all participants during registration.
: Not applicable.
: All authors are members of the HARMONY consortium. The authors declare that they have no other competing interests with regard to the Delphi study protocol. HCS, RG, and RSR are employed by Celgene, AbbVie, and Bayer, respectively.